Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer

Lung Cancer

Volumn 36, Issue 1, 2002, Pages 27-32

  Tanaka, Fumihiro ^a   Takata, Tetsuya ^a   Yamada, Tomoko ^a   Yanagihara, Kazuhiro ^a   Otake, Yosuke ^a   Miyahara, Ryo ^a   Nakagawa, Tatsuo ^a   Kawano, Yozo ^a   Ishikawa, Shinya ^a   Inui, Kenji ^a   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Non small cell lung cancer; P53; Proliferation; Surgery

Indexed keywords

PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036122037     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00462-7     Document Type: Article

References (32)

1. Apoptosis: A basic biological phenomenon with wide-ranging implication in tissue kinetics
2. p53-dependent apoptosis suppresses tumor growth and progression in vivo
3. Dormancy of micrometastasis: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
4. Apoptosis. Its significance in cancer and cancer therapy
5. The p53 tumor suppressor gene
6. p53 function and dysfunction
7. Apoptosis occurs more frequently in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin neck end labeling
8. Apoptosis and cellular proliferation in esophageal squamous cell carcinomas: Between keratinizing and nonkeratinizing types
9. Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein
10. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric interstitial-type carcinomas in vivo
11. Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasm
12. Accumulation of p53 protein correlates with poor prognosis in human lung cancer
13. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology and oncoprotein expression
14. The relationship of p53 immunostaining to survival in carcinoma of the lung
15. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer
16. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer
17. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
18. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer
19. Prognostic significance of apoptotic index in completely resected non-small cell lung cancer
20. Revisions in the international system for staging lung cancer
21. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
22. Cyclin/PCNA is the auxiliary protein of DNA polymerase ∂
23. Antigen expression and postoperative survival in non-small cell lung cancer
24. p53, guardian of the genome
25. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
26. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
27. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors
28. Increased expression of mutant form of p53 oncogene in primary lung cancer
29. Expression of mutant p53 protein in lung cancer correlates with the class of p53 gene mutation
30. p53 immunostaining positively is associated with reduced survival and imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871
31. Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alternations on apoptosis